» Articles » PMID: 29417141

Nonculprit Plaque Characteristics in Patients With Acute Coronary Syndrome Caused by Plaque Erosion Vs Plaque Rupture: A 3-Vessel Optical Coherence Tomography Study

Overview
Journal JAMA Cardiol
Date 2018 Feb 9
PMID 29417141
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Patients with culprit plaque rupture are known to have pancoronary plaque vulnerability. However, the characteristics of nonculprit plaques in patients with acute coronary syndromes caused by plaque erosion are unknown.

Objective: To investigate the nonculprit plaque phenotype in patients with acute coronary syndrome according to culprit plaque pathology (erosion vs rupture) by 3-vessel optical coherence tomography imaging.

Design, Setting, And Participants: In this observational cohort study, between August 2010 and May 2014, 82 patients with acute coronary syndrome who underwent preintervention optical coherence tomography imaging of all 3 major epicardial coronary arteries were enrolled at the Massachusetts General Hospital Optical Coherence Tomography Registry database. Analysis of the data was conducted between November 2016 and July 2017. Patients were classified into 2 groups based on the culprit lesion pathology: 17 patients with culprit plaque erosion and 34 patients with culprit plaque rupture. Thirty-one patients with the absence of culprit rupture or erosion were excluded from further analysis.

Exposures: Preintervention 3-vessel optical coherence tomography imaging.

Main Outcomes And Measures: Plaque characteristics at the culprit and nonculprit lesions evaluated by optical coherence tomography.

Results: In 51 patients (37 men; mean age, 58.7 years), the characteristics of 51 culprit plaques and 216 nonculprit plaques were analyzed. In patients with culprit erosion, the mean (SD) number of nonculprit plaques per patient was smaller (3.4 [1.9] in erosion vs 4.7 [2.1] in rupture, P = .05). Patient-based analysis showed that none of 17 patients with culprit plaque erosion had nonculprit plaque rupture, whereas 26% of the patients (9 of 34) with culprit plaque rupture had nonculprit plaque rupture (P = .02). Plaque-based analysis showed that, compared with the culprit rupture group (n = 158), the culprit erosion group (n = 58) had lower prevalence of plaque rupture (0% vs 8%; P < .001), macrophage accumulation (29% vs 53%; P = .01), microvessels (21% vs 42%; P = .003), and spotty calcium (5% vs 22%; P = .006) in the nonculprit lesions. The prevalence of lipid-rich plaque, thin-cap fibroatheroma, and thrombus did not differ between the groups.

Conclusions And Relevance: Compared with those with culprit plaque rupture, patients with acute coronary syndrome caused by culprit plaque erosion had a smaller number of nonculprit plaques and the lower levels of panvascular instability, affirming that distinct pathophysiologic mechanisms operate in plaque erosion and plaque rupture.

Citing Articles

Unlocking the Secrets of Acute Coronary Syndromes Using Intravascular Imaging: From Pathophysiology to Improving Outcomes.

Apostolos A, Karanasos A, Ktenopoulos N, Tsalamandris S, Vlachakis P, Kachrimanidis I J Clin Med. 2024; 13(23).

PMID: 39685545 PMC: 11642377. DOI: 10.3390/jcm13237087.


Tissue characteristics of residual lesion in patients with acute coronary syndrome caused by plaque rupture versus plaque erosion: a single-center, retrospective, observational study.

Suzuki W, Ohashi H, Ando H, Nakano Y, Takashima H, Fujimoto M Nagoya J Med Sci. 2024; 86(2):189-200.

PMID: 38962413 PMC: 11219232. DOI: 10.18999/nagjms.86.2.189.


Coronary Plaque Erosion: Epidemiology, Diagnosis, and Treatment.

Theofilis P, Vlachakis P, Papanikolaou A, Karakasis P, Oikonomou E, Tsioufis K Int J Mol Sci. 2024; 25(11).

PMID: 38891972 PMC: 11171599. DOI: 10.3390/ijms25115786.


Drug intervention as an emerging concept for secondary prevention in patients with coronary disease.

Minami Y, Ako J, Tsujita K, Yokoi H, Ikari Y, Morino Y Cardiovasc Interv Ther. 2024; 39(3):223-233.

PMID: 38587750 DOI: 10.1007/s12928-024-00994-7.


Morphological characteristics of in-stent restenosis with different degrees of area stenosis: an optical coherence tomography study.

Zhang W, Shen Y, Liu Z, Gu N, Rong J, Deng C Int J Cardiovasc Imaging. 2024; 40(4):699-708.

PMID: 38416297 DOI: 10.1007/s10554-023-03017-3.


References
1.
Otsuka F, Joner M, Prati F, Virmani R, Narula J . Clinical classification of plaque morphology in coronary disease. Nat Rev Cardiol. 2014; 11(7):379-89. DOI: 10.1038/nrcardio.2014.62. View

2.
Komukai K, Kubo T, Kitabata H, Matsuo Y, Ozaki Y, Takarada S . Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study. J Am Coll Cardiol. 2014; 64(21):2207-17. DOI: 10.1016/j.jacc.2014.08.045. View

3.
Prati F, Uemura S, Souteyrand G, Virmani R, Motreff P, Di Vito L . OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging. 2013; 6(3):283-7. DOI: 10.1016/j.jcmg.2012.12.007. View

4.
Ferrante G, Nakano M, Prati F, Niccoli G, Mallus M, Ramazzotti V . High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation. 2010; 122(24):2505-13. DOI: 10.1161/CIRCULATIONAHA.110.955302. View

5.
Fishbein M, Siegel R . How big are coronary atherosclerotic plaques that rupture?. Circulation. 1996; 94(10):2662-6. DOI: 10.1161/01.cir.94.10.2662. View